Additionally, if MRI reveals a fatty soft tissue tumor with heterogeneous signal intensity, septa < 2 mm, or a single non-fat nodule—regardless of the tumor’s maximum size—a biopsy with MDM2 determination is required to characterize the tumor before initiating treatment. This evidence concerns the gene MDM2 and neoplasm.